尤文肉瘤原发性瘤和转移的蛋白质学景观
Sagi Gordon1,2, Vishnu Mohan1, Rachel Shukrun2,3
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Nature communications
|March 12, 2026
概括
这项研究揭示了对尤文肉瘤 (EWS) 的新分子见解,尤文肉瘤是一种罕见的儿科骨癌. 研究结果将铁亡途径与化疗反应联系起来,并确定免疫细胞在EWS预后中的作用.
科学领域:
- 在瘤学瘤学.
- 蛋白质组学是指蛋白质组学.
- 癌症生物学 癌症生物学
背景情况:
- 尤文肉瘤 (EWS) 是一种罕见的儿科骨瘤,瘤微环境的了解很少,治疗选择有限.
- 应对这些挑战需要对EWS生物学有深刻的分子理解.
研究的目的:
- 在它们的微环境中对EWS瘤进行全面的蛋白质组分析.
- 确定影响EWS预后,化疗耐药性和进展的分子机制.
主要方法:
- 对来自74名患者的170个EWS瘤样本的基于深度质谱的蛋白质组分析.
- 分析包括原发性,复发性和转移性瘤.
- 多复合免疫光成像被用来评估瘤免疫格局.
主要成果:
- 鉴定了超过1万种蛋白质,为EWS生物学提供了洞察力.
- 铁亡途径与化疗反应有关.
- 分子子类与免疫细胞透 (中性粒细胞,巨细胞,T细胞) 与DNA损伤修复,与ubiquitin相关的蛋白质和患者的结果相关.
- 中性粒细胞的存在与更差的预后相关,而巨细胞和T细胞表明更有利的预后.
结论:
- 这项蛋白质组学研究为尤文肉瘤的复杂生物学提供了宝贵的见解.
- 这些发现突出了针对铁和免疫微环境的潜在治疗策略.
- 进一步的研究可以利用这些发现来改善EWS治疗.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...


